Live feed
Filing
SC 13D/A
SC 13D/A0001144204-17-028422·DMK PHARMACEUTICALS Corp
Schedule 13D ownership disclosure
Adamis Pharmaceuticals Corp
Security class unavailable · CUSIP: 00547W208
Event date: 2017-04-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-028422
- Form type
- SC 13D/A
- Filer
- DMK PHARMACEUTICALS Corp
- CIK
- CIK 887247
- Filed
- May 18, 2017
- Reporting period
- Apr 26, 2017
- Description
- Schedule 13D beneficial ownership